Tagged companies

rare-disease

2 companies

Deep Genomics

Toronto, ON, Canada · 2015

AI biotech company using deep learning to decode the genetic roots of disease and develop RNA-targeted therapeutics for rare genetic conditions.

High

Editas Medicine

Cambridge, MA, USA · 2013

Clinical-stage genome editing company developing CRISPR-based medicines targeting genetic diseases of the eye, blood, and liver.

High
×